Mitochondrial complex I-linked disease.

Area of Science:

• Biochemistry
• Genetics
• Mitochondrial Biology

Background:

• Complex I deficiency is the most frequent single enzyme defect in mitochondrial disorders.
• Leukodystrophy is a common clinical presentation, complicating diagnosis due to weak genotype-phenotype correlations.

Purpose of the Study:

• To review the diagnostic challenges and current therapeutic landscape for Complex I deficiency.
• To highlight recent advances in identifying genetic defects and developing novel treatment strategies.

Main Methods:

• Spectrophotometric enzyme activity assays on patient-derived tissues (muscle, liver, fibroblasts) have been the classical diagnostic approach.
• Advanced molecular genetic testing, including gene panels, exome, and genome sequencing, is increasingly identifying novel genetic causes.
• Analysis of secondary cellular effects, such as reactive oxygen species production and altered mitochondrial membrane potential.

Main Results:

• Numerous pathogenic mutations in nuclear and mitochondrial DNA genes encoding Complex I subunits have been identified.
• Novel genetic defects are continually being discovered through comprehensive genomic analyses.
• Secondary cellular dysfunctions, including oxidative stress and mitochondrial dysfunction, are induced by Complex I mutations.

Conclusions:

• Diagnosing Complex I deficiency remains challenging, necessitating advanced genetic testing alongside functional enzyme assays.
• Current treatments are primarily symptomatic, but emerging strategies targeting secondary cellular effects show therapeutic promise.
• Further research into genotype-phenotype correlations and novel therapeutic interventions is crucial for improving patient outcomes.